Therapeutics for tuberculosis

December 2006
Thorax;Dec2006 Supplement 2, Vol. 61, pii47
Academic Journal
The article presents abstracts of medical research about therapeutics for tuberculosis. They include "Tuberculosis Drug Related Hepatitis in Patients Treated With Standard Rifampicin/Isoniazid/Pyrazinamide Therapy Over a 25-Year Period," Outcome of Tuberculosis Treatment: Blackburn 1986-2005," and "Managing Multi-Drug Resistant Tuberculosis in the UK."


Related Articles

  • Peak plasma rifampicin level in tuberculosis patients with slow culture conversion. Chang, K.-C.; Leung, C.-C.; Yew, W.-W.; Kam, K.-M.; Yip, C.-W.; Ma, C.-H.; Tam, C.-M.; Leung, E.; Law, W.-S.; Leung, W.-M. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2008, Vol. 27 Issue 6, p467 

    The clinical utility of therapeutic drug monitoring in tuberculosis has not been adequately evaluated by controlled clinical trials. To examine the relationship between slow culture conversion and peak plasma rifampicin level (Cmax-rfm) in a case-control study, patients with persistence of...

  • Interleukin-6 Blood Levels in Sensitive and Multiresistant Tuberculosis. Correia, J. W.; Freitas, M. V.; Queiroz, J. A.; PereiraPerrin, M.; Cavadas, B. // Infection;Apr2009, Vol. 37 Issue 2, p138 

    Interleukin-6 (IL-6) is a proinflammatory cytokine implicated in the immunopathogenesis of tuberculosis (TB). Multidrug resistance in tuberculosis is recognized worldwide as an important public health issue. The mechanism underlying TB pathogenesis in general and drug resistance in particular is...

  • Does directly observed therapy (DOT) reduce drug resistant tuberculosis? Moonan, Patrick K.; Quitugua, Teresa N.; Pogoda, Janice M.; Woo, Gary; Drewyer, Gerry; Sahbazian, Behzad; Dunbar, Denise; Jost, Jr., Kenneth C.; Wallace, Charles; Weis, Stephen E. // BMC Public Health;2011, Vol. 11 Issue 1, p1 

    Background: Directly observed therapy (DOT) is a widely recommended and promoted strategy to manage tuberculosis (TB), however, there is still disagreement about the role of DOT in TB control and the impact it has on reducing the acquisition and transmission of drug resistant TB. This study...

  • Tuberculosis: drug resistance, fitness, and strategies for global control. Böttger, Erik C.; Springer, Burkhard; Böttger, Erik C // European Journal of Pediatrics;Feb2008, Vol. 167 Issue 2, p141 

    Directly observed standardized short-course chemotherapy (DOTS) regimes are an effective treatment for drug susceptible tuberculosis disease. Surprisingly, DOTS has been reported to reduce the transmission of multi-drug resistant tuberculosis, and standardized short-course chemotherapy regimens...

  • Europe is lagging behind in fight against tuberculosis. Moszynski, Peter // BMJ: British Medical Journal (International Edition);10/27/2007, Vol. 335 Issue 7625, p849 

    This article looks at the efforts of European ministers to reverse the prevalence of tuberculosis (TB) in Europe. The Berlin Declaration on Tuberculosis was passed after the forum heard that there were 445,000 new cases of TB in Europe during 2005 and 66,000 deaths as a result. The countries...

  • Management of hepatitis B reactivation in patients with lupus nephritis. Kai-Chung Tse; Yung, Susan; Tang, Colin; Yip, Terence Pok-Siu; Tak Mao Chan // Rheumatology International;Sep2009, Vol. 29 Issue 11, p1273 

    Hepatitis B is endemic in many Asian countries and immunosuppression may precipitate hepatitic flare. There is little data on the treatment of hepatitis B in patients with systemic lupus erythematosus. We monitored serial transaminase and HBV DNA levels in our HBsAg-positive patients with a...

  • Optimum Duration of Treatment for Hepatitis C.  // Clinical Oncology Alert;Sep2007 Supplement, Vol. 12 Issue 9, p18 

    The article discusses research being done on the optimum duration of treatment for hepatitis C. It references a study by M. L. Shiffman et al published in the 2007 issue of the "New England Journal of Medicine." The study found that the efficacy of the shorter course of therapy to achieve a...

  • Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis. Ooga, Hiromi; Suzuki, Fumitaka; Tsubota, Akihito; Arase, Yasuji; Suzuki, Yoshiyuki; Akuta, Norio; Sezaki, Hitomi; Hosaka, Tetsuya; Someya, Takashi; Kobayashi, Masahiro; Saitoh, Satoshi; Ikeda, Kenji; Kobayashi, Mariko; Matsuda, Marie; Satoh, Junko; Kumada, Hiromitsu // Journal of Gastroenterology;2004, Vol. 39 Issue 11, p1078 

    Background. Several clinical trials have suggested that lamivudine therapy is effective in patients with hepatitis B virus (HBV)-related cirrhosis. However, there are few studies of lamivudine therapy in Japanese patients with HBV cirrhosis. The aim of this study was to evaluate the efficacy of...

  • Evaluation of Deritis Ratio, Alkaline Phosphatase and Bilirubin in Liver Diseases. Rekha, M.; Jayaprakash Murthy, D. S.; Poornima, R. T.; Dattatreya, K. // Journal of Pharmaceutical Sciences & Research;2011, Vol. 3 Issue 3, p1096 

    Liver diseases are common disorders encountered in clinical practice. Investigations in Liver diseases are used to detect hepatic abnormality, to measure its severity, to define its structural effect on the liver to look for specific causes of Liver diseases to assess prognosis and to evaluate...


Read the Article


Sign out of this library

Other Topics